Recent Updates
Recently added Catalysts
QTRX Positive Sentiment

Quanterix Announces Leadership Transition Plan

Key Takeaway: Quanterix Corporation announced the immediate resignation of Everett Cunningham as President and CEO. Jim Gute, previously the Chief Commercial Officer, has been appointed as the new CEO. This leadership transition is expected to guide the company in its ongoing efforts in precision biomarker science.

Market Sentiment Analysis

POSITIVE FACTORS

  • Leadership transition may bring fresh perspectives.
  • Jim Gute has been appointed as the new CEO.
  • The company continues to evolve in the healthcare sector.

Full Press Release Details

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a global leader in precision biomarker science, today announced that Everett Cunningham has stepped down as President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective immediately, to accept an opportunity in another area of the healthcare sector. The Board has appointed Jim Gute, Quanterix’s Chief Commercial Officer, to serve in the addi

Frequently Asked Questions

Who has stepped down as CEO of Quanterix?

Everett Cunningham has stepped down as President and CEO.

Who is the new CEO of Quanterix?

Jim Gute has been appointed as the new CEO.

Why did Everett Cunningham resign?

He accepted an opportunity in another area of the healthcare sector.

What is Quanterix known for?

Quanterix is a leader in precision biomarker science.

Last updated: Nov 18, 2026